Objective:To explore the expression level of klk7 and E-cad in serum of patients with gastric cancer and to explore the relationship of klk7 and E-cad with gastric cancer clinical pathological characteristics.Method: ...Objective:To explore the expression level of klk7 and E-cad in serum of patients with gastric cancer and to explore the relationship of klk7 and E-cad with gastric cancer clinical pathological characteristics.Method: A total of 50 patients with gastric cancer, and 50 healthy persons were selected as the experimental group, benign gastric disease group and healthy group, respectively. A total of 24 patients in experimental group met surgery indications, and agreed to perform gastrectomy. They were divided into preoperative group and postoperative group. The serums levels of KLK7 and E-cad were detected by enzyme-linked immunosorbent assay.Results: The serum levels of KLK7 and E-cad were significantly higher than that of benign gastric disease group and normal control group. Compared with the experimental group after operation, MMP-2 and MMP-9 were decreased, KLK7 was significantly decreased and E-cad increased significantly after operation. Serum levels of KLK7 and E-cad in experimental group stage I were increased and stage IV decreased. Microvascular invasion was significantly correlated with serum KLK7 and E-cad. There was no significant correlation between tumor size, differentiation degree, depth and expression of KLK7 and E-cad. Serum KLK7 were significantly negatively correlated with E-cad expression in gastric cancer patients. Conclusions:KLK7 and E-cad are involved in the development and metastasis of gastric cancer. The serum expression of KLK7 and E-cad are significantly negatively correlated in patients with stomach cancer. There may be an antagonistic effect in gastric cancer development and metastasis. Serum level of KLK7 and E-cad can be used as indexes for progress monitoring.展开更多
文摘Objective:To explore the expression level of klk7 and E-cad in serum of patients with gastric cancer and to explore the relationship of klk7 and E-cad with gastric cancer clinical pathological characteristics.Method: A total of 50 patients with gastric cancer, and 50 healthy persons were selected as the experimental group, benign gastric disease group and healthy group, respectively. A total of 24 patients in experimental group met surgery indications, and agreed to perform gastrectomy. They were divided into preoperative group and postoperative group. The serums levels of KLK7 and E-cad were detected by enzyme-linked immunosorbent assay.Results: The serum levels of KLK7 and E-cad were significantly higher than that of benign gastric disease group and normal control group. Compared with the experimental group after operation, MMP-2 and MMP-9 were decreased, KLK7 was significantly decreased and E-cad increased significantly after operation. Serum levels of KLK7 and E-cad in experimental group stage I were increased and stage IV decreased. Microvascular invasion was significantly correlated with serum KLK7 and E-cad. There was no significant correlation between tumor size, differentiation degree, depth and expression of KLK7 and E-cad. Serum KLK7 were significantly negatively correlated with E-cad expression in gastric cancer patients. Conclusions:KLK7 and E-cad are involved in the development and metastasis of gastric cancer. The serum expression of KLK7 and E-cad are significantly negatively correlated in patients with stomach cancer. There may be an antagonistic effect in gastric cancer development and metastasis. Serum level of KLK7 and E-cad can be used as indexes for progress monitoring.